$GRWG

GrowGeneration (GRWG) Q2 2026 Earnings Call Transcript

GrowGeneration (GRWG) reported Q2 2026 revenue of $43.2 million, up 5.5% year over year, with adjusted EBITDA of $0.3 million versus a $1.3 million loss a year earlier. Net loss narrowed to $2.0 million. Gross margin rose to 28.5%. Full-year 2026 guidance: revenue $162-$168 million and adjusted EBITDA $2-$3 million. Cash was $41 million with no debt.

Original reporting
Published Aug 12, 2026, 2:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 3:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
GrowGeneration (GRWG) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$GRWGBullishMed
01

Why it matters

Key trading inputs are the raised full-year 2026 adjusted EBITDA range, Q3 revenue guidance, and management’s expectation that an IEPA tariff refund exceeding $2M will be recognized in Q3.

02

Market read

Investors get a quantified earnings and guidance update plus a specific Q3 catalyst (IEPA refund) that can drive near-term estimates and positioning.

03

What to watch

SG&A rose 5% year over year due to commercial sales structure investments, and the company is operating with about 25 fewer locations, which could pressure future growth if restructuring benefits fade.

Relevance 8/10Novelty 8/10Timing: post-market earnings call, guidance and IEPA refund timing discussed for Q3

Background

The article is a transcript of GrowGeneration’s Q2 2026 earnings call, covering results, segment performance, and 2026 guidance.

Company-level read

Ticker impact

$GRWGBullishMedium confidence
Context

GrowGeneration reported Q2 revenue of $43.2M, raised full-year 2026 adjusted EBITDA guidance to $2M-$3M, and guided Q3 revenue $44M-$46M.

Expected impact

Bias toward upside if investors focus on the raised adjusted EBITDA range and the expected IEPA refund; downside risk if storage gross profit and transportation costs persist.

Evidence & confidence

The call includes multiple quantified updates (Q2 results, raised FY adjusted EBITDA guidance, Q3 revenue range, and an IEPA refund expected to exceed $2M) that can re-rate near-term earnings power, but segment margin commentary and ongoing losses temper conviction.

Market effects

Cannabis retail and supply-chain names may see read-through on demand for higher-margin proprietary consumables and B2B platform traction.

Limited direct regional spillover; primarily US cannabis supply chain exposure.

Low global relevance; US-focused cannabis cultivation and storage supply.

Counterpoint

The upgraded adjusted EBITDA guidance may be overly dependent on the IEPA tariff refund timing, while storage segment gross profit dollars and transportation costs remain a headwind.

Key entities

  • GrowGeneration

    Reported Q2 2026 results and provided updated 2026 guidance, including raised adjusted EBITDA expectations and an IEPA tariff refund timing for Q3.

  • Darren Lampert

    CEO who discussed proprietary brand penetration, B2B platform progress, and acquisition philosophy.

  • Gregory Sanders

    CFO who discussed segment margin pressures and the IEPA tariff refund expected in Q3.

Related articles

$GRWGMedAI 8/10

GrowGeneration Beats on Q2 Earnings, Hikes '26 Adjusted EBITDA View

GrowGeneration Corp. (GRWG) reported Q2 2026 results: a 3-cent per-share loss, narrower than the Zacks Consensus estimate of a 4-cent loss and versus an 8-cent loss a year earlier. Sales rose 5.5% to $43.2M. Adjusted EBITDA was $0.3M. The company raised full-year adjusted EBITDA guidance to $2–$3M and reaffirmed sales guidance of $162–$168M.

$GRWGMedAI 8/10

GrowGeneration Corp. Q2 2026 Earnings Call Summary

GrowGeneration Corp. reported a third straight quarter of YoY revenue growth, citing a shift to a commercial B2B platform and proprietary brands. Proprietary brand penetration reached 40% ahead of schedule. The company cut store and operating expenses 22% YoY and raised full-year 2026 adjusted EBITDA guidance to $2M-$3M, aided by expected Q3 IEPA tariff refunds. It repurchased 700,000 shares at $1.38.

$EQIXMedAI 8/10

Equinix Is Doubling Down on AI Data Centers. How to Play EQIX Stock Here

Equinix (EQIX) reported Q2 revenue of $2.63B, up 16% YoY, beating estimates. AFFO was $11.78/share, up 19% YoY. The company raised full-year guidance and unveiled a multi-year growth plan. EQIX stock has surged 34% over the past year and offers a 1.98% dividend yield. Analysts rate it a 'Strong Buy' with an average price target of $1,232.19.

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.